SlideShare a Scribd company logo
1 of 22
 Definition of spectrum of sepsis
 Pathophysiology of sepsis
 Early Goal Directed Therapy
Infection SIRS
Sepsis
Severe
Sepsis
Septic
Shock
 Infection:
 Pathophysiologic abnormality caused by a microbial
pathogen
 Systemic Inflammatory Response Syndrome
(SIRS)
 > 2 of the following:
 Temp > 380C (100.4 F) or < 360C (96.8 F)
 Pulse > 90
 RR > 20 (or PaCO2 < 32)
 WBC > 12,000 or < 4,000 or > 10% bands
 CRP or procalcitonin > 2 SD above normal
 Sepsis:
 Presence of infection + SIRS
 Documented OR presumed infection
 Severe Sepsis:
 Sepsis + end organ dysfunction
 Signs of Hypoperfusion
 Lactic acidosis or Mottling
 Altered Mental Status
 Arterial Hypoxemia (PaO2:FiO2 < 300)
 Coagulation abnormalities (INR > 1.5)
 Thrombocytopenia (Platelets < 100,000)
 Ileus
 Renal, liver, cardiac failure
 Lab or vital sign abnormalities
 Septic Shock:
 Sepsis + refractory hypotension
 Hypotension:
 SBP < 90
 MAP < 65
 Decrease of 40 mm Hg SBP off baseline
 Refractory Hypotension:
 Hypotension despite 20 - 40 mL/kg crystalloid
challenge
 Lipopoloysaccharides and other bacterial
components activate neutrophils and vascular
endothelium
 Cytokines and complement activation lead to
vascular instability
 Increase in tissue factor leads to microvascular
occlusion
 Combination leads to coagulopathy,
vasodilation and capillary leak
 Early antibiotic therapy (within 1 hour of
presentation) decreases mortality
 Check hospital antibiogram
 Target the most likely source
 Start broad, narrow later
 When all else fails:
 Cefepime 1 gm IV and Vancomycin 15mg/kg
 Note: generally, anaerobes are NOT a cause of sepsis
except in rare intraabdominal cases
 Algorithmic approach to management of
severe sepsis
 Inclusion: 2/4 SIRS, SBP ≤90 after fluids or serum
lactate >4
 Then randomly assigned to standard therapy or EGDT
 With their EGDT protocol:
 Reduction in sudden cardiovascular collapse
 Mortality reduction:
 Standard therapy in-hospital mortality: 46.5%
 EGDT in-hospital mortality: 30.5% 16% Absolute
reduction in
mortality
 Patients with severe sepsis with signs of
hypoperfusion/end-organ dysfunction
 Lactate > 4 mmol/L
 (The patient does NOT need to be hypotensive)
 Patients with septic shock
 Goal-directed hemodynamic resuscitation of
severe sepsis / septic shock:
 Optimize CO: preload, afterload, and contractility
 Restore systemic oxygen content
 Oxygen Delivery (DO2) = CO x CaO2
 DO2 = CO x (1.34 * Hb * SaO2) + (0.003 * PaO2)
 Preserve tissue perfusion
 Avoid increases in myocardial O2 consumption
 CVP of 8 – 12 mm Hg
 Controversy about using CVP as no direct correlation to
volume responsiveness
 MAP of >65 mm Hg
 UOP ≥ 0.5 ml/kg/h
 Normalization of Lactate
 ScvO2 ≥ 70%
 ScvO2 = from CVP
 SvO2 = from PA catheter
 20-40ml/kg bolus
 Looking for recruitable CO
 Increase in BP with fluid challenge
 Pressors only after adequate fluid challenge
MAP <65 Fluid
Challenge
Pressors
 Vasopressors to MAP of > 65
 Once initial fluid resuscitation
has been completed*
 Arterial line placement is needed
at some point
 Pressors of choice
 Norepi +/- Vasopressin
 Epi
 If patient does not respond to
fluids and pressors,
Hydrocortisone should be given
ScvO2
<70
Transfuse
to HCT 30
Inotropes
 Achieve ScvO2 ≥ 70%
 Initial fluid resuscitation
 Blood transfusions to HCT >
30%**
 1 U PRBC will raise HCT ~ 3% or
Hgb 1 gram
 Inotropic therapy
 Decrease O2 consumption
 Major users are muscles of
respiration
 Intubation, sedation, and paralysis
may be needed
 Dobutamine
 Use when ScvO2 < 70% despite fluids and HCT >
30%
 Improves contractility
 Use in combination with vasopressor because of
vasodilatory effect
 Dose: 2.5 to 20 mcg/kg/min
 Major adverse effect: dysrhythmias
 Central Access in order to follow ScvO2
 Arterial Line: especially if patient requires
pressors
 Intubation if patient hypoxemic or with
significant altered mental status
 Early intubation can decrease oxygen consumption
by decreasing work of breathing
 Within 3 hours:
 Get lactate level
 Blood cx
 Abx (within 1hour)
 Fluid resuscitation
 Early recognition of sepsis is key in lowering
mortality
 Early antibiotics
 Early Goal Directed Therapy in appropriate
patients
 Appropriate access
 Being Aggressive

More Related Content

Similar to early goal direct therapy by emanuail revier

Copy (2) of sepsis present เซกา revised
Copy (2) of sepsis present เซกา revisedCopy (2) of sepsis present เซกา revised
Copy (2) of sepsis present เซกา revisedKit GenSx
 
Copy (2) of sepsis present เซกา revised
Copy (2) of sepsis present เซกา revisedCopy (2) of sepsis present เซกา revised
Copy (2) of sepsis present เซกา revisedKit GenSx
 
Icu management in obstructive airway disease
Icu management in obstructive airway diseaseIcu management in obstructive airway disease
Icu management in obstructive airway diseaseMuhammad Asim Rana
 
Icu management in obstructive airway disease
Icu management in obstructive airway diseaseIcu management in obstructive airway disease
Icu management in obstructive airway diseaseMuhammad Asim Rana
 
Class drug therapy of shock
Class drug therapy of shockClass drug therapy of shock
Class drug therapy of shockRaghu Prasada
 
Class drug therapy of shock
Class drug therapy of shockClass drug therapy of shock
Class drug therapy of shockRaghu Prasada
 
Critical care nephrology 26 6-2020
Critical care nephrology 26 6-2020Critical care nephrology 26 6-2020
Critical care nephrology 26 6-2020EmanElrefaie
 
Critical care nephrology 26 6-2020
Critical care nephrology 26 6-2020Critical care nephrology 26 6-2020
Critical care nephrology 26 6-2020EmanElrefaie
 
Hemodynamic Stabilisation In Septic Shock
Hemodynamic Stabilisation In Septic ShockHemodynamic Stabilisation In Septic Shock
Hemodynamic Stabilisation In Septic Shockchandra talur
 
Hemodynamic Stabilisation In Septic Shock
Hemodynamic Stabilisation In Septic ShockHemodynamic Stabilisation In Septic Shock
Hemodynamic Stabilisation In Septic Shockchandra talur
 

Similar to early goal direct therapy by emanuail revier (20)

Copy (2) of sepsis present เซกา revised
Copy (2) of sepsis present เซกา revisedCopy (2) of sepsis present เซกา revised
Copy (2) of sepsis present เซกา revised
 
Copy (2) of sepsis present เซกา revised
Copy (2) of sepsis present เซกา revisedCopy (2) of sepsis present เซกา revised
Copy (2) of sepsis present เซกา revised
 
shock
shockshock
shock
 
shock
shockshock
shock
 
Sepsis
SepsisSepsis
Sepsis
 
Sepsis
SepsisSepsis
Sepsis
 
Icu management in obstructive airway disease
Icu management in obstructive airway diseaseIcu management in obstructive airway disease
Icu management in obstructive airway disease
 
Icu management in obstructive airway disease
Icu management in obstructive airway diseaseIcu management in obstructive airway disease
Icu management in obstructive airway disease
 
Sepsis and Septic Shock.pptx
Sepsis and Septic Shock.pptxSepsis and Septic Shock.pptx
Sepsis and Septic Shock.pptx
 
Sepsis and Septic Shock.pptx
Sepsis and Septic Shock.pptxSepsis and Septic Shock.pptx
Sepsis and Septic Shock.pptx
 
Class drug therapy of shock
Class drug therapy of shockClass drug therapy of shock
Class drug therapy of shock
 
Class drug therapy of shock
Class drug therapy of shockClass drug therapy of shock
Class drug therapy of shock
 
Critical care nephrology 26 6-2020
Critical care nephrology 26 6-2020Critical care nephrology 26 6-2020
Critical care nephrology 26 6-2020
 
Critical care nephrology 26 6-2020
Critical care nephrology 26 6-2020Critical care nephrology 26 6-2020
Critical care nephrology 26 6-2020
 
Sepsis dr samra
Sepsis dr samraSepsis dr samra
Sepsis dr samra
 
Sepsis dr samra
Sepsis dr samraSepsis dr samra
Sepsis dr samra
 
Fundamentals of ICU
Fundamentals of ICUFundamentals of ICU
Fundamentals of ICU
 
Fundamentals of ICU
Fundamentals of ICUFundamentals of ICU
Fundamentals of ICU
 
Hemodynamic Stabilisation In Septic Shock
Hemodynamic Stabilisation In Septic ShockHemodynamic Stabilisation In Septic Shock
Hemodynamic Stabilisation In Septic Shock
 
Hemodynamic Stabilisation In Septic Shock
Hemodynamic Stabilisation In Septic ShockHemodynamic Stabilisation In Septic Shock
Hemodynamic Stabilisation In Septic Shock
 

More from DrJoharAljohar

7_telemedicine services _panel_pptx.pptx
7_telemedicine services _panel_pptx.pptx7_telemedicine services _panel_pptx.pptx
7_telemedicine services _panel_pptx.pptxDrJoharAljohar
 
ischemic stroke and hemorrhagic in adult
ischemic stroke and hemorrhagic  in adultischemic stroke and hemorrhagic  in adult
ischemic stroke and hemorrhagic in adultDrJoharAljohar
 
ICU_one_pager_hyperthermi.pdf
ICU_one_pager_hyperthermi.pdfICU_one_pager_hyperthermi.pdf
ICU_one_pager_hyperthermi.pdfDrJoharAljohar
 
34936_Evaluation of a patient with Jaundice.ppt
34936_Evaluation of a patient with Jaundice.ppt34936_Evaluation of a patient with Jaundice.ppt
34936_Evaluation of a patient with Jaundice.pptDrJoharAljohar
 
3- human 3 genetics without genetic counseling.ppt
3- human 3 genetics without genetic counseling.ppt3- human 3 genetics without genetic counseling.ppt
3- human 3 genetics without genetic counseling.pptDrJoharAljohar
 

More from DrJoharAljohar (6)

7_telemedicine services _panel_pptx.pptx
7_telemedicine services _panel_pptx.pptx7_telemedicine services _panel_pptx.pptx
7_telemedicine services _panel_pptx.pptx
 
ischemic stroke and hemorrhagic in adult
ischemic stroke and hemorrhagic  in adultischemic stroke and hemorrhagic  in adult
ischemic stroke and hemorrhagic in adult
 
ICU_one_pager_hyperthermi.pdf
ICU_one_pager_hyperthermi.pdfICU_one_pager_hyperthermi.pdf
ICU_one_pager_hyperthermi.pdf
 
infection SMLE
infection SMLEinfection SMLE
infection SMLE
 
34936_Evaluation of a patient with Jaundice.ppt
34936_Evaluation of a patient with Jaundice.ppt34936_Evaluation of a patient with Jaundice.ppt
34936_Evaluation of a patient with Jaundice.ppt
 
3- human 3 genetics without genetic counseling.ppt
3- human 3 genetics without genetic counseling.ppt3- human 3 genetics without genetic counseling.ppt
3- human 3 genetics without genetic counseling.ppt
 

Recently uploaded

Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingTechSoup
 
Hybridoma Technology ( Production , Purification , and Application )
Hybridoma Technology  ( Production , Purification , and Application  ) Hybridoma Technology  ( Production , Purification , and Application  )
Hybridoma Technology ( Production , Purification , and Application ) Sakshi Ghasle
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionSafetyChain Software
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...Marc Dusseiller Dusjagr
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Educationpboyjonauth
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxheathfieldcps1
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdfssuser54595a
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdfSoniaTolstoy
 
URLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website AppURLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website AppCeline George
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptxVS Mahajan Coaching Centre
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfciinovamais
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Celine George
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfsanyamsingh5019
 
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptxContemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptxRoyAbrique
 
Separation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesSeparation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesFatimaKhan178732
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxSayali Powar
 
Student login on Anyboli platform.helpin
Student login on Anyboli platform.helpinStudent login on Anyboli platform.helpin
Student login on Anyboli platform.helpinRaunakKeshri1
 

Recently uploaded (20)

Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy Consulting
 
Hybridoma Technology ( Production , Purification , and Application )
Hybridoma Technology  ( Production , Purification , and Application  ) Hybridoma Technology  ( Production , Purification , and Application  )
Hybridoma Technology ( Production , Purification , and Application )
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory Inspection
 
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptxINDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Education
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
 
URLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website AppURLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website App
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17
 
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdfTataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdf
 
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptxContemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
 
Separation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesSeparation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and Actinides
 
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
 
Student login on Anyboli platform.helpin
Student login on Anyboli platform.helpinStudent login on Anyboli platform.helpin
Student login on Anyboli platform.helpin
 

early goal direct therapy by emanuail revier

  • 1.
  • 2.  Definition of spectrum of sepsis  Pathophysiology of sepsis  Early Goal Directed Therapy
  • 4.  Infection:  Pathophysiologic abnormality caused by a microbial pathogen  Systemic Inflammatory Response Syndrome (SIRS)  > 2 of the following:  Temp > 380C (100.4 F) or < 360C (96.8 F)  Pulse > 90  RR > 20 (or PaCO2 < 32)  WBC > 12,000 or < 4,000 or > 10% bands  CRP or procalcitonin > 2 SD above normal
  • 5.  Sepsis:  Presence of infection + SIRS  Documented OR presumed infection  Severe Sepsis:  Sepsis + end organ dysfunction
  • 6.  Signs of Hypoperfusion  Lactic acidosis or Mottling  Altered Mental Status  Arterial Hypoxemia (PaO2:FiO2 < 300)  Coagulation abnormalities (INR > 1.5)  Thrombocytopenia (Platelets < 100,000)  Ileus  Renal, liver, cardiac failure  Lab or vital sign abnormalities
  • 7.  Septic Shock:  Sepsis + refractory hypotension  Hypotension:  SBP < 90  MAP < 65  Decrease of 40 mm Hg SBP off baseline  Refractory Hypotension:  Hypotension despite 20 - 40 mL/kg crystalloid challenge
  • 8.  Lipopoloysaccharides and other bacterial components activate neutrophils and vascular endothelium  Cytokines and complement activation lead to vascular instability  Increase in tissue factor leads to microvascular occlusion  Combination leads to coagulopathy, vasodilation and capillary leak
  • 9.  Early antibiotic therapy (within 1 hour of presentation) decreases mortality  Check hospital antibiogram  Target the most likely source  Start broad, narrow later  When all else fails:  Cefepime 1 gm IV and Vancomycin 15mg/kg  Note: generally, anaerobes are NOT a cause of sepsis except in rare intraabdominal cases
  • 10.  Algorithmic approach to management of severe sepsis  Inclusion: 2/4 SIRS, SBP ≤90 after fluids or serum lactate >4  Then randomly assigned to standard therapy or EGDT  With their EGDT protocol:  Reduction in sudden cardiovascular collapse  Mortality reduction:  Standard therapy in-hospital mortality: 46.5%  EGDT in-hospital mortality: 30.5% 16% Absolute reduction in mortality
  • 11.  Patients with severe sepsis with signs of hypoperfusion/end-organ dysfunction  Lactate > 4 mmol/L  (The patient does NOT need to be hypotensive)  Patients with septic shock
  • 12.  Goal-directed hemodynamic resuscitation of severe sepsis / septic shock:  Optimize CO: preload, afterload, and contractility  Restore systemic oxygen content  Oxygen Delivery (DO2) = CO x CaO2  DO2 = CO x (1.34 * Hb * SaO2) + (0.003 * PaO2)  Preserve tissue perfusion  Avoid increases in myocardial O2 consumption
  • 13.  CVP of 8 – 12 mm Hg  Controversy about using CVP as no direct correlation to volume responsiveness  MAP of >65 mm Hg  UOP ≥ 0.5 ml/kg/h  Normalization of Lactate  ScvO2 ≥ 70%  ScvO2 = from CVP  SvO2 = from PA catheter
  • 14.  20-40ml/kg bolus  Looking for recruitable CO  Increase in BP with fluid challenge  Pressors only after adequate fluid challenge
  • 16.  Vasopressors to MAP of > 65  Once initial fluid resuscitation has been completed*  Arterial line placement is needed at some point  Pressors of choice  Norepi +/- Vasopressin  Epi  If patient does not respond to fluids and pressors, Hydrocortisone should be given
  • 18.  Achieve ScvO2 ≥ 70%  Initial fluid resuscitation  Blood transfusions to HCT > 30%**  1 U PRBC will raise HCT ~ 3% or Hgb 1 gram  Inotropic therapy  Decrease O2 consumption  Major users are muscles of respiration  Intubation, sedation, and paralysis may be needed
  • 19.  Dobutamine  Use when ScvO2 < 70% despite fluids and HCT > 30%  Improves contractility  Use in combination with vasopressor because of vasodilatory effect  Dose: 2.5 to 20 mcg/kg/min  Major adverse effect: dysrhythmias
  • 20.  Central Access in order to follow ScvO2  Arterial Line: especially if patient requires pressors  Intubation if patient hypoxemic or with significant altered mental status  Early intubation can decrease oxygen consumption by decreasing work of breathing
  • 21.  Within 3 hours:  Get lactate level  Blood cx  Abx (within 1hour)  Fluid resuscitation
  • 22.  Early recognition of sepsis is key in lowering mortality  Early antibiotics  Early Goal Directed Therapy in appropriate patients  Appropriate access  Being Aggressive

Editor's Notes

  1. SIRS is a sign of inflammation, not infection
  2. EGDT added TLC with measurement and management of SvO2 In hospital as well as 28 and 60 day mortality was reduced
  3. *hypovolemia still may not be resolved but may require pressors after initial fluid challenge
  4. HCT 30 goal only for first 6 hours of resus  then goal transfusion goal <7 unless patient with ongoing ischemia, hemorrhage or severe hypoxemia and resolution of tissue hypoperfusion
  5. SvO2 - True mixed venous oxygen saturation from PA catheter,  ScvO2 - Central venous oxygen saturation from TLC Target >65% for SvO2 (5% difference due to the mixing of venous blood from the atrial and coronary sinus blood)